GSM5460478[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 3

Select item 2001803031.

Predictive Models of Drug Response in Canine Osteosarcoma: A Prospective Clinical Trial Testing the COXEN Approach

(Submitter supplied) This was a prospective clinical trial testing the ability of gene expression models of drug sensitivity that were developed in human and canine cell lines and applied to outcomes in dogs treated with adjuvant carboplatin and/or doxorubicin. Tumor samples were collected prospectively, and gene expression analysis was conducted using Affymetrix Canine Genome 2.0 Arrays.

Organism:: Canis lupus familiaris

Type:: Expression profiling by array

Platform:: GPL3738
109 Samples

Download data: CEL

Series

Accession:: GSE180303

ID:: 200180303

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 1000037382.

[Canine_2] Affymetrix Canine Genome 2.0 Array

(Submitter supplied) Affymetrix submissions are typically submitted to GEO using the GEOarchive method described at http://www.ncbi.nlm.nih.gov/projects/geo/info/geo_affy.html The GeneChip® Canine Genome 2.0 Array enables researchers to simultaneously interrogate 18,000 C. familiaris mRNA/EST-based transcripts and over 20,000 non-redundant predicted genes. Sequence information for this array includes content from Canis familiaris UniGene Build #11 (April, 2005), GenBank® mRNAs up to April 15, 2005, as well as the BROADD1 gene predictions from the boxer dog genome, downloaded from EBI on May 9, 2005. more...